Lymphocyte proliferation panel, Blood
While monitoring absolute lymphocyte counts is useful in disease diagnosis, evaluating the functional capacity of these cells is equally important. Functional lymphocyte assessment determines whether T-cells can proliferate adequately upon stimulation, which is a vital indicator of robust immune function. The lymphocyte proliferation panel evaluates T-cell responsiveness to two main types of stimuli:
- Mitogens: Non-specific plant lectins (e.g., phytohemagglutinin [PHA], concanavalin A [ConA], pokeweed mitogen [PWM]) that strongly stimulate lymphocytes regardless of prior antigen exposure.
- Antigens: Specific proteins such as tetanus toxoid, tuberculin purified protein derivative (PPD), and Candida albicans, which assess antigen-specific cellular memory responses.
This assessment involves isolating T-cells from peripheral blood via density gradient separation (typically Ficoll-Paque), then exposing them to the selected stimuli in vitro. After 3–7 days of incubation, T-cell proliferation is quantified using various methods, such as radioactive thymidine (3H-thymidine) incorporation, ATP-based bioluminescence assays, or flow cytometry assays utilizing carboxyfluorescein succinimidyl ester (CFSE) or bromodeoxyuridine (BrdU) to measure cellular proliferation and DNA synthesis. Lymphopenia (low T-cell counts) can artificially lower observed proliferation. However, flow cytometry analysis compensates for this effect by precisely identifying proliferating cell populations.
- Diagnosing immunodeficiency disorders due to impaired T-cell function (e.g., SCID, DiGeorge syndrome, HIV/AIDS)
- Evaluating and monitoring T-cell function in patients undergoing immunosuppressive therapy, including transplant recipients, autoimmune patients, and oncology patients receiving chemotherapy
Increased proliferation:
- Autoimmune diseases
- Lymphoproliferative disorders
- Chronic inflammatory conditions
- Allergic reactions and drug hypersensitivities
Decreased proliferation:
- Primary T-cell immunodeficiency
- HIV/AIDS
- Post-chemotherapy
- Post immunosuppressive therapy
- Malnutrition
- Chronic infections from TB or EBV
- High-dose or long term low-dose corticosteroid therapy
| Parameter | Reference Value |
| Viability of lymphocytes (Day 0) | ≥75.0% |
| Maximum Proliferation of Phytohemagglutinin (PHA) | Reference Value |
| % CD45-positive cells | ≥49.9% |
| % CD3-positive cells | ≥58.5% |
| Maximum Proliferation of Pokeweed Mitogen (PWM) | Reference Value |
| % CD45-positive cells | ≥4.5% |
| % CD3-positive cells | ≥3.5% |
| % CD19-positive cells | ≥3.9% |
Whole blood, sodium heparin (Green) vial, blood filled up to the black label on the vial, 20mL blood required which approximates 5 vials.
Stability
- Ambient: 48 hours
- Refrigerated: Unacceptable
- Frozen: Unacceptable
- Methods Mol Med. 1999:17:343-53. [PMID: 21380686]
- J Immunol Methods. 2025 Feb;537:113819. [PMID: 39855541]
- Clin Immunol. 2014 Aug;153(2):332-42. [PMID: 24909732]
- Clin Immunol. 2024 Apr;261:109942. [PMID: 38367737]